levodopa has been researched along with Coronary Artery Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ng, CF; Norlinah, MI; Tan, HJ; Tiau, PW | 1 |
| Diaz-Arrastia, R; Frol, AB; Rogers, JD; Sanchez-Saffon, A | 1 |
| Lizogub, VG; Piatak, OA; Yanovskii, GV | 1 |
1 trial(s) available for levodopa and Coronary Artery Disease
| Article | Year |
|---|---|
The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
Topics: Adult; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Exercise Test; Hemodynamics; Humans; Levodopa; Middle Aged; Nonachlazine; Oxprenolol; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1991 |
2 other study(ies) available for levodopa and Coronary Artery Disease
| Article | Year |
|---|---|
Levodopa-induced myocardial infarction in a patient with Parkinson's disease and severe coronary artery disease.
Topics: Aged; Antiparkinson Agents; Coronary Angiography; Coronary Artery Disease; Electrocardiography; Humans; Levodopa; Male; Non-ST Elevated Myocardial Infarction; Parkinson Disease; Severity of Illness Index | 2019 |
Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Middle Aged; Parkinson Disease; Risk Factors; Vitamin B 12 | 2003 |